Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

PharmaMar initiates Phase I study of PM1183 to treat patients with solid tumours in Japan

Go Top